Abstract | BACKGROUND: METHODS: Three groups of schizophrenia patients were recruited- drug free (n = 5), typical antipsychotic treated (n = 7), and clozapine treated (n = 9)-as well as a control group of healthy normal volunteers (n = 13). All underwent [123I] CNS-1261 SPET scanning. Total volume of distribution of [123I] CNS-1261 was determined within predefined user-independent regions of interest after alignment of all images to a common template. RESULTS: There was no apparent difference in total volume of distribution of [123I] CNS-1261 in drug-free patients relative to healthy control subjects. A nonsignificant reduction in total volume of distribution was observed in typical antipsychotic treated patients. A significant decline in total volume of distribution of [123I] CNS-1261 was observed in all examined brain regions in the clozapine-treated patient group relative to healthy control subjects (p < .005). CONCLUSIONS:
|
Authors | Rodrigo A Bressan, Kjell Erlandsson, James M Stone, Rachel S Mulligan, John H Krystal, Peter J Ell, Lyn S Pilowsky |
Journal | Biological psychiatry
(Biol Psychiatry)
Vol. 58
Issue 1
Pg. 41-6
(Jul 01 2005)
ISSN: 0006-3223 [Print] United States |
PMID | 15992521
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antipsychotic Agents
- CNS 1261
- Guanidines
- Iodine Radioisotopes
- Receptors, N-Methyl-D-Aspartate
- Clozapine
|
Topics |
- Adult
- Antipsychotic Agents
(pharmacology, therapeutic use)
- Clozapine
(pharmacology, therapeutic use)
- Dose-Response Relationship, Drug
- Female
- Guanidines
(metabolism)
- Humans
- Iodine Radioisotopes
(metabolism)
- Male
- Receptors, N-Methyl-D-Aspartate
(drug effects, metabolism, physiology)
- Schizophrenia
(diagnostic imaging, drug therapy, physiopathology)
- Tomography, Emission-Computed, Single-Photon
|